{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:41:20Z","timestamp":1793835680930,"version":"4.6.1"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Immunology and Immunopathology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.vetimm.2026.111109","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T23:32:08Z","timestamp":1774135928000},"page":"111109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Reframing veterinary vaccine quality control: Integrating alternative assays within lifecycle-based regulatory frameworks"],"prefix":"10.1016","volume":"296","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2202-9544","authenticated-orcid":false,"given":"Mohamed Samy","family":"Abousenna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vetimm.2026.111109_bib1","unstructured":"{C}Magnusson B., \u00d6rnemark U.{C}, editors. Eurachem Guide: The Fitness for Purpose of Analytical Methods \u2013 A Laboratory Guide to Method Validation and Related Topics. 2nd ed. 2014. Available from: \u3008www.eurachem.org\u3009."},{"issue":"1","key":"10.1016\/j.vetimm.2026.111109_bib2","first-page":"9","article-title":"Emergency evaluation for existing vaccine against recently isolated FMDV type SAT2 in Egypt 2018","volume":"31","author":"Abousenna","year":"2022","journal-title":"VacciMonitor"},{"issue":"1","key":"10.1016\/j.vetimm.2026.111109_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.17582\/journal.jahp\/2020\/8.1.8.12","article-title":"Using of rapid ELISA as an alternative method for evaluation of canine parvo vaccines","volume":"8","author":"Abousenna","year":"2020","journal-title":"J. Anim. Health Prod."},{"issue":"2","key":"10.1016\/j.vetimm.2026.111109_bib4","first-page":"45","article-title":"Using real-time PCR as a tool for quantification of sheep pox virus","volume":"8","author":"Abousenna","year":"2020","journal-title":"J. Anim. Health Prod."},{"issue":"1","key":"10.1016\/j.vetimm.2026.111109_bib5","article-title":"Preliminary evaluation of humoral immune response to rabies vaccine using lateral flow immunochromatographic assay","volume":"34","author":"Abousenna","year":"2025","journal-title":"VacciMonitor"},{"key":"10.1016\/j.vetimm.2026.111109_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2025.115327","article-title":"Real-time PCR-based evaluation of live attenuated lumpy skin disease virus vaccines for immunogenicity and efficacy","author":"Abousenna","year":"2026","journal-title":"J. Virol. Methods"},{"issue":"1","key":"10.1016\/j.vetimm.2026.111109_bib7","first-page":"4","article-title":"Alternative method for the evaluation of monovalent inactivated foot and mouth disease virus vaccine","volume":"30","author":"Abousenna","year":"2021","journal-title":"VacciMonitor"},{"key":"10.1016\/j.vetimm.2026.111109_bib8","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1038\/s41598-025-88906-4","article-title":"Emergency response for recently isolated foot-and-mouth disease virus type A Africa in Egypt 2022","volume":"15","author":"Abousenna","year":"2025","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.vetimm.2026.111109_bib9","first-page":"165","article-title":"Sensitivity of lateral flow device for evaluation of inactivated Rift Valley fever virus vaccine in sheep","volume":"10","author":"Abousenna","year":"2020","journal-title":"World Vet. J."},{"key":"10.1016\/j.vetimm.2026.111109_bib10","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1038\/s41598-024-55548-x","article-title":"Sensitivity of lateral flow technique for diagnosis of canine parvovirus","volume":"14","author":"Abousenna","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.vetimm.2026.111109_bib11","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1038\/s41598-025-87831-w","article-title":"Evaluation of humoral immune response and milk antibody transfer in calves and lactating cows vaccinated with inactivated H5 avian influenza vaccine","volume":"15","author":"Abousenna","year":"2025","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.vetimm.2026.111109_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/104063879200400301","article-title":"Competitive ELISA for serodiagnosis of bluetongue: evaluation of group-specific monoclonal antibodies and expressed VP7 antigen","volume":"4","author":"Afshar","year":"1992","journal-title":"J. Vet. Diagn. Invest"},{"key":"10.1016\/j.vetimm.2026.111109_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nmeth.2365","article-title":"The FlowCAP Consortium, The DREAM Consortium, Hoos H, Mosmann TR, et al. Critical assessment of automated flow cytometry data analysis techniques","volume":"10","author":"Aghaeepour","year":"2013","journal-title":"Nat. Methods"},{"issue":"6","key":"10.1016\/j.vetimm.2026.111109_bib14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/tbed.12015","article-title":"Emergence of foot-and-mouth disease virus SAT2 in Egypt during 2012","volume":"59","author":"Ahmed","year":"2012","journal-title":"Transbound. Emerg. Dis."},{"issue":"5","key":"10.1016\/j.vetimm.2026.111109_bib15","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.talanta.2010.08.033","article-title":"Screen-printed biosensors in microbiology; a review","volume":"82","author":"Alonso-Lomillo","year":"2010","journal-title":"Talanta"},{"issue":"9","key":"10.1016\/j.vetimm.2026.111109_bib16","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.14202\/vetworld.2018.1222-1228","article-title":"Assessment of in vitro potency of inactivated Newcastle disease oil-adjuvanted vaccines using hemagglutination test and blocking ELISA","volume":"11","author":"Aly","year":"2018","journal-title":"Vet. World"},{"issue":"8","key":"10.1016\/j.vetimm.2026.111109_bib17","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1128\/CVI.00229-13","article-title":"Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattle","volume":"20","author":"Anderson","year":"2013","journal-title":"Clin. Vaccin. Immunol."},{"key":"10.1016\/j.vetimm.2026.111109_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fneur.2015.00179","article-title":"A practical guide to immunoassay method validation","volume":"6","author":"Andreasson","year":"2015","journal-title":"Front Neurol."},{"key":"10.1016\/j.vetimm.2026.111109_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetimm.2025.111003","article-title":"Comparative efficacy of a field-strain matched bivalent inactivated vaccine against contemporary Newcastle disease and infectious bronchitis viruses in Egypt","volume":"288","author":"Azab","year":"2025","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2026.111109_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.trac.2013.02.014","article-title":"Analytical characterization of biosimilar antibodies and Fc-fusion proteins","volume":"48","author":"Beck","year":"2013","journal-title":"TrAC Trends Anal. Chem."},{"issue":"1","key":"10.1016\/j.vetimm.2026.111109_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12917-022-03362-w","article-title":"Development and evaluation of a bead-based Multiplexed Fluorescent ImmunoAssay (MFIA) for detection of antibodies to Salmonella enterica serogroup B and C1 in pigs","volume":"18","author":"Berger","year":"2022","journal-title":"BMC Vet. Res"},{"key":"10.1016\/j.vetimm.2026.111109_bib22","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1039\/C9LC00104B","article-title":"Sensitivity enhancement in lateral flow assays: a systems perspective","volume":"19","author":"Bishop","year":"2019","journal-title":"Lab Chip"},{"key":"10.1016\/j.vetimm.2026.111109_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1147028","article-title":"An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines","volume":"14","author":"Bodle","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.vetimm.2026.111109_bib24","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/s41587-020-0513-4","article-title":"CRISPR\u2013Cas12-based detection of SARS-CoV-2","volume":"38","author":"Broughton","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.vetimm.2026.111109_bib25","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMp0900702","article-title":"Digital disease detection \u2014 harnessing the Web for public health surveillance","volume":"360","author":"Brownstein","year":"2009","journal-title":"N. Engl. J. Med"},{"issue":"5","key":"10.1016\/j.vetimm.2026.111109_bib26","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1177\/1040638717710451","article-title":"Analytical validation of a reference laboratory ELISA for the detection of feline leukemia virus p27 antigen","volume":"29","author":"Buch","year":"2017","journal-title":"J. Vet. Diagn. Invest"},{"issue":"2","key":"10.1016\/j.vetimm.2026.111109_bib27","first-page":"198","article-title":"Pioneering better science through the 3Rs: an introduction to the national centre for the replacement, refinement, and reduction of animals in research (NC3Rs)","volume":"54","author":"Burden","year":"2015","journal-title":"J. Am. Assoc. Lab Anim. Sci."},{"key":"10.1016\/j.vetimm.2026.111109_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2024.1413420","article-title":"Rapid lateral flow immunoassay for fluorescence detection of canine distemper virus (CDV)","volume":"11","author":"Cao","year":"2024","journal-title":"Front Vet. Sci."},{"issue":"3","key":"10.1016\/j.vetimm.2026.111109_bib29","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/tbed.13768","article-title":"Improving laboratory diagnostic capacities of emerging diseases using knowledge mapping","volume":"68","author":"Cargnel","year":"2021","journal-title":"Transbound. Emerg. Dis."},{"key":"10.1016\/j.vetimm.2026.111109_bib30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.biologicals.2017.02.002","article-title":"G-protein based ELISA as a potency test for rabies vaccines","volume":"46","author":"Chabaud-Riou","year":"2017","journal-title":"Biologicals"},{"key":"10.1016\/j.vetimm.2026.111109_bib31","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/ni.2796","article-title":"Single-cell technologies for monitoring immune systems","volume":"15","author":"Chattopadhyay","year":"2014","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.vetimm.2026.111109_bib32","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1586\/erv.09.20","article-title":"Opportunities and challenges of developing thermostable vaccines","volume":"8","author":"Chen","year":"2009","journal-title":"Expert Rev. Vaccin."},{"issue":"6387","key":"10.1016\/j.vetimm.2026.111109_bib33","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aar6245","article-title":"CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity","volume":"360","author":"Chen","year":"2018","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.vetimm.2026.111109_bib34","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3390\/vaccines10091473","article-title":"Development of an ELISA-Based Potency Assay for Inactivated Influenza Vaccines Using Cross-Reactive Nanobodies","volume":"10","author":"Cheung","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"10.1016\/j.vetimm.2026.111109_bib35","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1177\/1040638713507256","article-title":"Opportunities for bead-based multiplex assays in veterinary diagnostic laboratories","volume":"25","author":"Christopher-Hennings","year":"2013","journal-title":"J. Vet. Diagn. Invest"},{"issue":"6","key":"10.1016\/j.vetimm.2026.111109_bib36","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/jps.21143","article-title":"Inhibition of aggregation of aluminum hydroxide adjuvant during freezing and drying","volume":"97","author":"Clausi","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.vetimm.2026.111109_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4236\/ojvm.2012.21003","article-title":"Epidemiological aspects and clinicopathological findings in cats naturally infected with feline leukemia virus (FeLV) and\/or feline immunodeficiency virus (FIV)","volume":"2","author":"Collado","year":"2012","journal-title":"Open J. Vet. Med"},{"key":"10.1016\/j.vetimm.2026.111109_bib38","series-title":"The ELISA Guidebook","author":"Crowther","year":"2009"},{"issue":"4","key":"10.1016\/j.vetimm.2026.111109_bib39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.14573\/altex.1509081","article-title":"Animal use for science in Europe","volume":"32","author":"Daneshian","year":"2015","journal-title":"ALTEX"},{"key":"10.1016\/j.vetimm.2026.111109_bib40","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/ni.3768","article-title":"Systems immunology: just getting started","volume":"18","author":"Davis","year":"2017","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.vetimm.2026.111109_bib41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13567-020-00869-8","article-title":"Fowl adenovirus (FAdV) fiber-based vaccine against inclusion body hepatitis (IBH) provides type-specific protection guided by humoral immunity and regulation of B and T cell response","volume":"51","author":"De Luca","year":"2020","journal-title":"Vet Res."},{"issue":"7","key":"10.1016\/j.vetimm.2026.111109_bib42","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nbt.1661","article-title":"Options and considerations when selecting a quantitative proteomics strategy","volume":"28","author":"Domon","year":"2010","journal-title":"Nat Biotechnol."},{"key":"10.1016\/j.vetimm.2026.111109_bib43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nrmicro2240","article-title":"Viruses as vaccine vectors for infectious diseases and cancer","volume":"8","author":"Draper","year":"2010","journal-title":"Nat. Rev. Microbiol"},{"key":"10.1016\/j.vetimm.2026.111109_bib44","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2015"},{"issue":"10","key":"10.1016\/j.vetimm.2026.111109_bib45","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.2460\/javma.1991.199.10.1339","article-title":"Use of western blot and radioimmunoprecipitation for diagnosis of feline leukemia and feline immunodeficiency virus infections","volume":"199","author":"Egberink","year":"1991","journal-title":"J. Am. Vet. Med Assoc."},{"issue":"32","key":"10.1016\/j.vetimm.2026.111109_bib46","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1016\/j.vaccine.2023.06.051","article-title":"Assessing the stability-indicating properties of alternative potency assays for inactivated influenza vaccine","volume":"41","author":"Ekimov","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vetimm.2026.111109_bib47","unstructured":"European Commission. Directive 2010\/63\/EU on the protection of animals used for scientific purposes. Official Journal of the European Union, 2010; L 276\/33."},{"key":"10.1016\/j.vetimm.2026.111109_bib48","unstructured":"European Medicines Agency. Guideline on quality, safety and efficacy of veterinary vaccines. EMA\/CVMP\/IWP\/206555\/2010. Amsterdam: EMA; 2019. Available at: \u3008https:\/\/www.ema.europa.eu\u3009."},{"issue":"3","key":"10.1016\/j.vetimm.2026.111109_bib49","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11259-025-10667-2","article-title":"Progress in diagnostic methods and vaccines for lumpy skin disease virus: a path towards understanding the disease","volume":"49","author":"Farag","year":"2025","journal-title":"Vet. Res Commun."},{"issue":"2","key":"10.1016\/j.vetimm.2026.111109_bib50","doi-asserted-by":"crossref","DOI":"10.1208\/aapsj0902029","article-title":"Appropriate calibration curve fitting in ligand binding assays","volume":"9","author":"Findlay","year":"2007","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.vetimm.2026.111109_bib51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/vaccines12010027","article-title":"Cytokines, Serological, and Histopathological Assessment of Recombinant Vaccination Strategies for Combatting Infectious Bursal Disease in Broiler Chickens","volume":"12","author":"Gewaily","year":"2024","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.vetimm.2026.111109_bib52","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/vr.g143","article-title":"The evolution of One Health: a decade of progress and challenges for the future","volume":"174","author":"Gibbs","year":"2014","journal-title":"Vet. Rec."},{"issue":"2","key":"10.1016\/j.vetimm.2026.111109_bib53","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.rvsc.2013.03.016","article-title":"Quantitation of cytokine gene expression by real time PCR in bovine milk and colostrum cells from cows immunized with an experimental rotavirus vaccine","volume":"95","author":"Gonz\u00e1lez","year":"2013","journal-title":"Res Vet. Sci."},{"issue":"6336","key":"10.1016\/j.vetimm.2026.111109_bib54","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1126\/science.aam9321","article-title":"Nucleic acid detection with CRISPR-Cas13a\/C2c2","volume":"356","author":"Gootenberg","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.vetimm.2026.111109_bib55","series-title":"Immunoassays: A Practical Approach. Oxford","author":"Gosling","year":"2000"},{"issue":"5","key":"10.1016\/j.vetimm.2026.111109_bib56","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/10495398.2020.1735404","article-title":"Evaluation of real-time PCR as an alternative for potency testing of Brucella abortus vaccines","volume":"32","author":"Gupta","year":"2021","journal-title":"Anim. Biotechnol."},{"key":"10.1016\/j.vetimm.2026.111109_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2022.198960","article-title":"Molecular detection and phylogenetic analysis of newly emerging FMDV type A EURO-SA in Egypt, 2022","volume":"323","author":"Hagag","year":"2023","journal-title":"Virus Res"},{"key":"10.1016\/j.vetimm.2026.111109_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2020.554305","article-title":"Novel Foot-and-Mouth Disease Vaccine Platform: Formulations for Safe and DIVA-Compatible FMD Vaccines With Improved Potency","volume":"7","author":"Hardham","year":"2020","journal-title":"Front Vet. Sci."},{"key":"10.1016\/j.vetimm.2026.111109_bib59","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12985-021-01693-y","article-title":"Molecular detection and genetic diversity of FMDV serotype A African topotype IV","volume":"19","author":"Hassan","year":"2022","journal-title":"Virol. J."},{"issue":"4","key":"10.1016\/j.vetimm.2026.111109_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001413","article-title":"Big data opportunities for global infectious disease surveillance","volume":"10","author":"Hay","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.vetimm.2026.111109_bib61","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.3390\/ani13193141","article-title":"Utilizing Electrochemical Biosensors as an Innovative Platform for the Rapid and On-Site Detection of Animal Viruses","volume":"13","author":"He","year":"2023","journal-title":"Animals"},{"issue":"3","key":"10.1016\/j.vetimm.2026.111109_bib62","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/14760584.8.3.313","article-title":"Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement","volume":"8","author":"Hendriksen","year":"2009","journal-title":"Expert Rev. Vaccin."},{"issue":"22","key":"10.1016\/j.vetimm.2026.111109_bib63","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1021\/ac202028g","article-title":"High-throughput droplet digital PCR system for absolute quantitation of DNA copy number","volume":"83","author":"Hindson","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.vetimm.2026.111109_bib64","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bios.2015.08.032","article-title":"Membrane-based lateral flow immunochromatographic strip with nanoparticles as reporters for detection: a review","volume":"75","author":"Huang","year":"2016","journal-title":"Biosens. Bioelectron."},{"issue":"6","key":"10.1016\/j.vetimm.2026.111109_bib65","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1373\/clinchem.2013.206375","article-title":"The digital MIQE guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments","volume":"59","author":"Huggett","year":"2013","journal-title":"Clin. Chem."},{"key":"10.1016\/j.vetimm.2026.111109_bib66","unstructured":"International Conference on Harmonisation. ICH Q8(R2): Pharmaceutical development. Geneva: ICH; 2009. Available at: \u3008https:\/\/www.ich.org\u3009."},{"key":"10.1016\/j.vetimm.2026.111109_bib67","unstructured":"International Organization for Standardization. ISO\/IEC 17025:2017 General requirements for the competence of testing and calibration laboratories. Geneva: ISO; 2017."},{"issue":"1","key":"10.1016\/j.vetimm.2026.111109_bib68","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4014\/jmb.1006.06006","article-title":"Validation of a real-time RT-PCR method to quantify Newcastle Disease Virus (NDV) titer and comparison with other quantifiable methods","volume":"21","author":"Jang","year":"2011","journal-title":"J. Microbiol Biotechnol."},{"key":"10.1016\/j.vetimm.2026.111109_bib69","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1038\/s41596-019-0210-2","article-title":"SHERLOCK: nucleic acid detection with CRISPR nucleases","volume":"14","author":"Kellner","year":"2019","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.vetimm.2026.111109_bib70","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/vaccines12010010","article-title":"An Alternative Serological Measure for Assessing Foot-and-Mouth Disease Vaccine Efficacy against Homologous and Heterologous Viral Challenges in Pigs","volume":"12","author":"Kim","year":"2024","journal-title":"Vaccines"},{"issue":"3-4","key":"10.1016\/j.vetimm.2026.111109_bib71","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.prevetmed.2013.07.013","article-title":"The economic impacts of foot and mouth disease - what are they, how big are they and where do they occur?","volume":"112","author":"Knight-Jones","year":"2013","journal-title":"Prev Vet Med."},{"issue":"1","key":"10.1016\/j.vetimm.2026.111109_bib72","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1042\/EBC20150012","article-title":"Lateral flow assays","volume":"60","author":"Koczula","year":"2016","journal-title":"Essays Biochem"},{"key":"10.1016\/j.vetimm.2026.111109_bib73","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fpubh.2016.00007","article-title":"Who owns the data? Open data for healthcare","volume":"4","author":"Kostkova","year":"2016","journal-title":"Front Public Health"},{"issue":"5","key":"10.1016\/j.vetimm.2026.111109_bib74","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.biologicals.2014.05.007","article-title":"Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies","volume":"42","author":"Kumru","year":"2014","journal-title":"Biologicals"},{"key":"10.1016\/j.vetimm.2026.111109_bib75","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ni.2789","article-title":"Molecular signatures of antibody responses derived from a systems biology study of five human vaccines","volume":"15","author":"Li","year":"2014","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.vetimm.2026.111109_bib76","first-page":"168","article-title":"Correlation between 146S Antigen Content in Foot-and-Mouth Disease Inactivated Vaccines and Immunogenicity Level and Vaccine Potency Alternative Test Methods","volume":"11","author":"Li","year":"2024","journal-title":"Vet. Sci."},{"key":"10.1016\/j.vetimm.2026.111109_bib77","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.virusres.2016.10.018","article-title":"Evidence of VP1 of duck hepatitis A type 1 virus as a target of neutralizing antibodies and involving receptor-binding activity","volume":"227","author":"Li","year":"2017","journal-title":"Virus Res"},{"key":"10.1016\/j.vetimm.2026.111109_bib78","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01484-25","article-title":"Recent advances in lateral flow devices and point-of-care diagnostics for highly pathogenic avian influenza A viruses","volume":"99","author":"Lin","year":"2025","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.vetimm.2026.111109_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0013010","article-title":"Assessing anti-rabies vaccine response in humans: A rapid and high-throughput adaptable, pseudovirus-based neutralization assay as an alternative to rapid fluorescent focus inhibition test (RFFIT)","volume":"19","author":"Lupitha","year":"2025","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"4","key":"10.1016\/j.vetimm.2026.111109_bib80","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/01652176.2000.9695063","article-title":"Antigen quantification as in vitro alternative for potency testing of inactivated viral poultry vaccines","volume":"22","author":"Maas","year":"2000","journal-title":"Vet. Q"},{"issue":"2","key":"10.1016\/j.vetimm.2026.111109_bib81","first-page":"88","article-title":"The One Health Approach\u2014Why Is It So Important?","volume":"4","author":"Mackenzie","year":"2019","journal-title":"Trop. Med Infect. Dis."},{"key":"10.1016\/j.vetimm.2026.111109_bib82","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri3158","article-title":"Standardizing immunophenotyping for the Human Immunology Project","volume":"12","author":"Maecker","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.vetimm.2026.111109_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2022.113386","article-title":"Development of ELISA for the detection of antibodies against VP2 protein of bluetongue virus serotype-1","volume":"511","author":"Mahapatra","year":"2022","journal-title":"J. Immunol. Methods"},{"issue":"10","key":"10.1016\/j.vetimm.2026.111109_bib84","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1002\/jmv.25986","article-title":"Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE-based colorimetric live virus micro-neutralization assay in human serum samples","volume":"92","author":"Manenti","year":"2020","journal-title":"J. Med Virol."},{"key":"10.1016\/j.vetimm.2026.111109_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.1058335","article-title":"Reporting on 16 years of laboratory capacity building while exploring the future of WOAH's Laboratory Twinning Programme","volume":"9","author":"Marrana","year":"2022","journal-title":"Front Vet. Sci."},{"issue":"1","key":"10.1016\/j.vetimm.2026.111109_bib86","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/vaccines3010090","article-title":"Assaying the Potency of Influenza Vaccines","volume":"3","author":"Minor","year":"2015","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.vetimm.2026.111109_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008142","article-title":"Inactivated rabies vaccines: Standardization of an in vitro assay for residual viable virus detection","volume":"14","author":"Moreira","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.vetimm.2026.111109_bib88","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1038\/s41467-020-17892-0","article-title":"A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation","volume":"11","author":"Muruato","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.vetimm.2026.111109_bib89","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ni.2067","article-title":"Systems biology of seasonal influenza vaccination in humans","volume":"12","author":"Nakaya","year":"2011","journal-title":"Nat. Immunol."},{"issue":"29","key":"10.1016\/j.vetimm.2026.111109_bib90","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1016\/j.vaccine.2011.09.061","article-title":"The mechanism of action of MF59 - an innately attractive adjuvant formulation","volume":"30","author":"O'Hagan","year":"2012","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vetimm.2026.111109_bib91","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/0300985814540545","article-title":"Advancement of knowledge of Brucella over the past 50 years","volume":"51","author":"Olsen","year":"2014","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.vetimm.2026.111109_bib92","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines \u2014 a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9-10","key":"10.1016\/j.vetimm.2026.111109_bib93","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.micinf.2017.12.006","article-title":"Alternative strategies for vaccination to brucellosis","volume":"20","author":"Pascual","year":"2018","journal-title":"Microbes Infect."},{"issue":"2","key":"10.1016\/j.vetimm.2026.111109_bib94","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/vaccines3020320","article-title":"Vaccine Adjuvants: from 1920 to 2015 and Beyond","volume":"3","author":"Pasquale","year":"2015","journal-title":"Vaccines"},{"key":"10.1016\/j.vetimm.2026.111109_bib95","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nri1416","article-title":"Seventeen-colour flow cytometry: unravelling the immune system","volume":"4","author":"Perfetto","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.vetimm.2026.111109_bib96","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin. Vaccin. Immunol."},{"issue":"4","key":"10.1016\/j.vetimm.2026.111109_bib97","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/laban.1217","article-title":"Improving quality of science through better animal welfare: the NC3Rs strategy","volume":"46","author":"Prescott","year":"2017","journal-title":"Lab Anim. (NY)"},{"issue":"4","key":"10.1016\/j.vetimm.2026.111109_bib98","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.immuni.2010.10.006","article-title":"Systems vaccinology","volume":"33","author":"Pulendran","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.vetimm.2026.111109_bib99","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.vetimm.2026.111109_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194830","article-title":"An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations","volume":"13","author":"Rajendran","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.vetimm.2026.111109_bib101","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nbt0109-26","article-title":"Quality by design for biopharmaceuticals","volume":"27","author":"Rathore","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.vetimm.2026.111109_bib102","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med"},{"issue":"3-4","key":"10.1016\/j.vetimm.2026.111109_bib103","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.prevetmed.2010.08.002","article-title":"The economic and poverty impacts of animal diseases in developing countries: new roles, new demands for economics and epidemiology","volume":"101","author":"Rich","year":"2011","journal-title":"Prev. Vet. Med"},{"issue":"2","key":"10.1016\/j.vetimm.2026.111109_bib104","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/vim.2008.0007","article-title":"Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses","volume":"21","author":"Roehrig","year":"2008","journal-title":"Viral Immunol."},{"issue":"5","key":"10.1016\/j.vetimm.2026.111109_bib105","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1007\/s13361-016-1531-9","article-title":"A Retrospective Evaluation of the Use of Mass Spectrometry in FDA Biologics License Applications","volume":"28","author":"Rogstad","year":"2017","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.vetimm.2026.111109_bib106","unstructured":"Russell W.M.S., Burch R.L. The Principles of Humane Experimental Technique. London: Methuen; 1959. Reprinted 1992, Universities Federation for Animal Welfare, Wheathampstead, UK."},{"issue":"7","key":"10.1016\/j.vetimm.2026.111109_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002616","article-title":"Digital epidemiology","volume":"8","author":"Salath\u00e9","year":"2012","journal-title":"PLoS Comput. Biol."},{"issue":"17","key":"10.1016\/j.vetimm.2026.111109_bib108","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1021\/ac103230c","article-title":"Evaluation of digital PCR for absolute DNA quantification","volume":"83","author":"Sanders","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.vetimm.2026.111109_bib109","article-title":"Evaluation of live attenuated canine parvovirus vaccines using real-time PCR","volume":"33","author":"Shafik","year":"2024","journal-title":"VacciMonitor"},{"issue":"1","key":"10.1016\/j.vetimm.2026.111109_bib110","first-page":"35","article-title":"Efficacy of a local trivalent FMD vaccine against recently isolated O-EA3","volume":"8","author":"Shafik","year":"2019","journal-title":"Int J. Vet. Sci."},{"issue":"3","key":"10.1016\/j.vetimm.2026.111109_bib111","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.21931\/RB\/2021.01.03.12","article-title":"Comparative study between lumpy skin disease virus and sheep pox virus vaccines against recent field isolate of lumpy skin disease virus","volume":"6","author":"Shafik","year":"2021","journal-title":"Bionatura"},{"issue":"7","key":"10.1016\/j.vetimm.2026.111109_bib112","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.14202\/vetworld.2023.1429-1437","article-title":"Circulating FMDV serotype A African genotype IV in Egypt during 2022","volume":"16","author":"Shahein","year":"2023","journal-title":"Vet. World"},{"key":"10.1016\/j.vetimm.2026.111109_bib113","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1663259","article-title":"Assessment of immune responses to Brucella abortus S19 vaccination in cattle and buffaloes","volume":"16","author":"Shome","year":"2025","journal-title":"Front Immunol."},{"issue":"5","key":"10.1016\/j.vetimm.2026.111109_bib114","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1051\/vetres:2000135","article-title":"Enzyme-linked immunosorbent assay with a Salmonella enteritidis antigen for differentiating infected from vaccinated poultry","volume":"31","author":"Solano","year":"2000","journal-title":"Vet. Res"},{"issue":"7","key":"10.1016\/j.vetimm.2026.111109_bib115","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.tibtech.2018.12.002","article-title":"The Ultimate qPCR Experiment: Producing Publication Quality, Reproducible Data the First Time","volume":"37","author":"Taylor","year":"2019","journal-title":"Trends Biotechnol."},{"issue":"5","key":"10.1016\/j.vetimm.2026.111109_bib116","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1128\/CVI.00034-14","article-title":"Comparison of test methodologies for foot-and-mouth disease virus serotype A vaccine matching","volume":"21","author":"Tekleghiorghis","year":"2014","journal-title":"Clin. Vaccin. Immunol."},{"issue":"3","key":"10.1016\/j.vetimm.2026.111109_bib117","first-page":"185","article-title":"Immune response following vaccination against Salmonella Enteritidis using 2 commercial bacterins in laying hens","volume":"74","author":"Tran","year":"2010","journal-title":"Can. J. Vet. Res"},{"key":"10.1016\/j.vetimm.2026.111109_bib118","first-page":"36","article-title":"Development of real-time and lateral flow dipstick recombinase polymerase amplification assays for rapid detection of goatpox virus and sheeppox virus","volume":"14","author":"Tu","year":"2017","journal-title":"Virol. J."},{"issue":"3","key":"10.1016\/j.vetimm.2026.111109_bib119","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/vaccines2030624","article-title":"Developments in viral vector-based vaccines","volume":"2","author":"Ura","year":"2014","journal-title":"Vaccines"},{"issue":"10","key":"10.1016\/j.vetimm.2026.111109_bib120","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1080\/14760584.2021.1977628","article-title":"Overcoming scientific barriers in the transition from in vivo to non-animal batch testing of human and veterinary vaccines","volume":"20","author":"van den Biggelaar","year":"2021","journal-title":"Expert Rev. Vaccin."},{"issue":"10","key":"10.1016\/j.vetimm.2026.111109_bib121","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3390\/vaccines9101150","article-title":"Pentavalent Disabled Infectious Single Animal (DISA)\/DIVA Vaccine Provides Protection in Sheep and Cattle against Different Serotypes of Bluetongue Virus","volume":"9","author":"van Rijn","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.vetimm.2026.111109_bib122","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.768869","article-title":"Development Real-Time PCR Assays to Genetically Differentiate Vaccinated Pigs From Infected Pigs With the Eurasian Strain of African Swine Fever Virus","volume":"8","author":"Velazquez-Salinas","year":"2021","journal-title":"Front Vet. Sci."},{"key":"10.1016\/j.vetimm.2026.111109_bib123","unstructured":"VICH. VICH GL50: Harmonisation of criteria for waiving target animal batch safety testing for inactivated vaccines for veterinary use. 2007. Available from: \u3008https:\/\/www.ema.europa.eu\/en\/vich-gl50-harmonisation-criteria-waiving-target-animal-batch-safety-testing-inactivated-vaccines\u3009."},{"key":"10.1016\/j.vetimm.2026.111109_bib124","unstructured":"VICH. VICH GL55: Studies to evaluate the safety and efficacy of veterinary vaccines. 2011. Available from: \u3008https:\/\/www.ema.europa.eu\/en\/vich-gl55-studies-evaluate-safety-efficacy-veterinary-vaccines\u3009."},{"issue":"36","key":"10.1016\/j.vetimm.2026.111109_bib125","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1016\/j.vaccine.2005.04.023","article-title":"Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency","volume":"23","author":"Wang","year":"2005","journal-title":"Vaccine."},{"issue":"11","key":"10.1016\/j.vetimm.2026.111109_bib126","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gks203","article-title":"Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation","volume":"40","author":"Whale","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vetimm.2026.111109_bib127","series-title":"WHO guidelines on the use of cell substrates for the production of biologicals","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.vetimm.2026.111109_bib128","series-title":"Terrestrial Manual","article-title":"Brucellosis (infection with Brucella abortus, B. melitensis and B. suis) Chapter 3.1.4","author":"World Organisation for Animal Health (WOAH)","year":"2022"},{"key":"10.1016\/j.vetimm.2026.111109_bib129","series-title":"Manual of diagnostic tests and vaccines for terrestrial animals (mammals, birds, bees)","first-page":"1","article-title":"Foot and Mouth Disease (infection with foot and mouth disease)","author":"World Organisation for Animal Health (WOAH)","year":"2022"},{"key":"10.1016\/j.vetimm.2026.111109_bib130","series-title":"Terrestrial Animal Health Manual","article-title":"Chapter 3.8.9. Peste des petits ruminants (infection with small ruminant morbillivirus)","author":"World Organisation for Animal Health (WOAH)","year":"2022"},{"key":"10.1016\/j.vetimm.2026.111109_bib131","series-title":"Terrestrial Manual","article-title":"Rift Valley Fever (infection with Rift Valley fever virus)","author":"World Organisation for Animal Health (WOAH)","year":"2023"},{"key":"10.1016\/j.vetimm.2026.111109_bib132","series-title":"Terrestrial Animal Health Code and Manual (on Diagnosis and Vaccine Standards","author":"World Organisation for Animal Health (WOAH)","year":"2024"},{"key":"10.1016\/j.vetimm.2026.111109_bib133","series-title":"Developing standards for diagnostic tests (Quality Veterinary Products section)","author":"World Organisation for Animal Health (WOAH)","year":"2024"},{"key":"10.1016\/j.vetimm.2026.111109_bib134","series-title":"WOAH Terrestrial Animal Health Manual","article-title":"Chapter 3.8.12. Sheep pox and goat pox","author":"World Organisation for Animal Health (WOAH)","year":"2024"},{"issue":"7","key":"10.1016\/j.vetimm.2026.111109_bib135","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3390\/vaccines13070721","article-title":"Simple and High-Throughput Quantification of Mono- and Bivalent Foot-and-Mouth Disease Virus Vaccine Antigens by Differential Scanning Fluorimetry","volume":"13","author":"Yang","year":"2025","journal-title":"Vaccin. (Basel)"},{"issue":"1","key":"10.1016\/j.vetimm.2026.111109_bib136","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11515-012-1196-0","article-title":"Progress in Brucella vaccine development","volume":"8","author":"Yang","year":"2013","journal-title":"Front Biol. (Beijing)"},{"issue":"1","key":"10.1016\/j.vetimm.2026.111109_bib137","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/mas.20190","article-title":"Mass spectrometry for structural characterization of therapeutic antibodies","volume":"28","author":"Zhang","year":"2009","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.vetimm.2026.111109_bib138","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2025.1611428","article-title":"Development and validation of a qPCR assay for residual host cell DNA in rabies vaccines","volume":"13","author":"Zhao","year":"2025","journal-title":"Front Bioeng. Biotechnol."}],"container-title":["Veterinary Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242726000486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242726000486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:14:12Z","timestamp":1778300052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165242726000486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":138,"alternative-id":["S0165242726000486"],"URL":"https:\/\/doi.org\/10.1016\/j.vetimm.2026.111109","relation":{},"ISSN":["0165-2427"],"issn-type":[{"value":"0165-2427","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reframing veterinary vaccine quality control: Integrating alternative assays within lifecycle-based regulatory frameworks","name":"articletitle","label":"Article Title"},{"value":"Veterinary Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vetimm.2026.111109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111109"}}